Ownership history in Birchview Capital, LP · 27 quarters on record
This page tracks every 13F SEC filing in which Birchview Capital, LP reported a position in ACADIA PHARMACEUTICALS INC (ACAD). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | UNCHANGED | 171,000 | — | 0% | 2.67% | $4.6M | $26.71 |
| 2025 Q3 | REDUCED | 171,000 | -16,800 | -8.9% | 2.76% | $3.6M | $21.34 |
| 2025 Q2 | REDUCED | 187,800 | -75,600 | -28.7% | 4.02% | $4.1M | $21.57 |
| 2025 Q1 | REDUCED | 263,400 | -75,000 | -22.2% | 3.80% | $4.4M | $16.61 |
| 2024 Q4 | REDUCED | 338,400 | -62,000 | -15.5% | 5.06% | $6.2M | $18.35 |
| 2024 Q3 | ADDED | 400,400 | +150,000 | +59.9% | 5.34% | $6.2M | $15.38 |
| 2024 Q2 | UNCHANGED | 250,400 | — | 0% | 3.77% | $4.1M | $16.25 |
| 2024 Q1 | ADDED | 250,400 | +10,000 | +4.2% | 3.78% | $4.6M | $18.49 |
| 2023 Q4 | UNCHANGED | 240,400 | — | 0% | 5.90% | $7.5M | $31.31 |
| 2023 Q3 | REDUCED | 240,400 | -9,000 | -3.6% | 4.26% | $5.0M | $20.84 |
As of 2025 Q4 — sorted by position size